Abridge Expands AI Platform to Inpatient Care and Clinical Decision Support
The AI scribing company is evolving into a clinical intelligence layer through partnerships with Epic and major medical associations.
Abridge is expanding its AI capabilities beyond ambient scribing to create a comprehensive clinical intelligence layer for healthcare providers. The company is shifting its focus toward supporting clinicians throughout the entire patient encounter, from pre-visit preparation to post-visit documentation.
As part of this expansion, Abridge has launched "Abridge Inside for Inpatient," a tool co-developed with Epic. This offering streamlines inpatient workflows, specifically targeting the creation of consult notes, progress notes, and history and physical documentation. The technology has already seen significant adoption, with deployment across more than 100 health systems.
Beyond documentation, the platform now integrates a clinical decision support feature. To ensure these tools are grounded in medical evidence, Abridge established content collaborations with several prestigious medical organizations and publications, including the American Academy of Family Physicians, the American Diabetes Association, the JAMA network, The New England Journal of Medicine, and Wolters Kluwer's UpToDate.
The Shift Toward Clinical Intelligence
Abridge began as a specialized AI scribing tool aimed at reducing clinician burnout by automating medical note-taking. As the market for AI scribes has matured, the company is repositioning itself as a "clinical conversation foundation model." By integrating deeply with Electronic Health Records (EHRs) like Epic, Abridge is moving into higher-value functions such as order entry and evidence-based decision support.
This evolution is supported by strategic financial and research partnerships. Eli Lilly and Co. has made a strategic investment in Abridge to support research initiatives and assist in the identification of potential candidates for clinical trials.
Implications for Healthcare Delivery
This transition from a documentation tool to a clinical "copilot" addresses a systemic crisis in healthcare: the lack of time providers have to adhere to national recommended care guidelines. By automating clerical burdens and providing real-time, evidence-based intelligence, Abridge aims to reduce the cognitive load on clinicians.
"Our mission in many ways, from a product perspective, is to go millions of miles deep on all the different ways that we can help unburden clinicians from clerical work," said Shiv Rao, M.D., CEO of Abridge. He noted that this expansion brings "trusted intelligence into the most important moment in medicine: a clinician caring for a patient."
Future Outlook
The company's trajectory suggests a move toward a more holistic operating system for the clinical encounter. Observers will be watching how the integration of decision support affects patient outcomes and whether the partnership with Epic allows for seamless scaling across other EHR environments. The success of the Eli Lilly investment will also indicate how effectively ambient AI can be leveraged for pharmaceutical research and trial recruitment.